Target intelligence / Profile preview

Potassium inward rectifier channel subfamily J member 3 (KCNJ3)

Target
KCNJ3
Molecular classification
Ion channel, Inward rectifier potassium channel
01

Overview

Potassium inward rectifier channel subfamily J member 3 (KCNJ3), commonly referred to as GIRK1, is a transmembrane protein that serves as a core subunit of G protein-activated inward rectifier potassium (GIRK) channels. These channels are predominantly localized in the central nervous system and the cardiac atria, where they play a fundamental role in controlling membrane excitability [UniProt: P48549]. Upon the activation of G protein-coupled receptors (GPCRs), such as the muscarinic M2 or adenosine A1 receptors, liberated Gβγ subunits bind directly to the GIRK complex, causing the channel to open and allowing potassium ions to flow out of the cell [PubMed: 10457636]. This efflux results in membrane hyperpolarization, which in the heart slows the heart rate (the IKACh current) and in the brain modulates neuronal firing rates [PubMed: 25484347]. Pathologically, KCNJ3 has been implicated in the development of atrial fibrillation and certain forms of epilepsy, and it has recently emerged as a potential biomarker and driver for metastasis in breast cancer [PubMed: 29532585]. Pharmacological efforts are currently focused on developing subunit-selective inhibitors, like NTC-801, to treat supraventricular arrhythmias while minimizing off-target effects in other tissues [PubMed: 30045831].

Other names
GIRK1KIR3.1KGAInward rectifier K(+) channel Kir3.1BIR1
02

Mechanism of action

Modulation of potassium efflux through G protein-activated inward rectifier complexes to regulate cellular membrane potential and excitability.

03

Biological functions

Membrane hyperpolarizationHeart rate regulationSignal transductionPotassium ion transportG protein-coupled receptor signaling pathway
04

Disease associations

Atrial fibrillationBreast cancerEpilepsySchizophreniaKeppen-Lubinsky syndrome
05

Safety considerations

BradycardiaAtrioventricular blockPro-arrhythmic risk in specific cardiac conditionsCentral nervous system depression
06

Interacting drugs

NTC-801

6 more in the full profile.

07

Biomarkers

KCNJ3 mRNA expressionGIRK1 protein levels in atrial tissueIKACh current density

Beyond the preview

Go deeper on Potassium inward rectifier channel subfamily J member 3 (KCNJ3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium inward rectifier channel subfamily J member 3 (KCNJ3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call